High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers

Breast Cancer Research and Treatment

Volumn 135, Issue 1, 2012, Pages 177-187

  Chew, G L ^a   Huang, D ^b   Lin, S J ^a,c   Huo, C ^a   Blick, T ^b   Henderson, M A ^a,c   Hill, P ^a,d   Cawson, J ^a   Morrison, W A ^a,e   Campbell, I G ^c   Hopper, J L ^a   Southey, M C ^a   Haviv, I ^f   Thompson, E W ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d St Vincent's Pathology   (Australia)

^e O'Brien Institute of Microsurgery   (Australia)

^f BAR ILAN UNIVERSITY   (Israel)

Author keywords

Bioengineering chambers; Breast density; Mammographic density; Murine; Stroma

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; MASTECTOMY; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STEREOTACTIC BIOPSY; TISSUE ENGINEERING; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MICE; MICE, SCID; STROMAL CELLS; TISSUE ENGINEERING; TISSUE TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84865128541     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2128-z     Document Type: Article

References (31)

1. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356(3):227-236. doi: (Pubitemid 46143226)
2. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6(10):798-808. doi: 10.1016/S1470-2045(05)70390-9
3. McCormack VA, dos Santos SI (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 15(6):1159-1169. doi: 10.1158/1055-9965.EPI-06-0034
4. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomark Prev 12(4):332-338 (Pubitemid 36427994)
5. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87(21):1622-1629
6. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87(9):670-675
7. Wolfe JN, Saftlas AF, Salane M (1987) Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol 148(6):1087-1092 (Pubitemid 17083062)
8. Byrne C, Schairer C, Brinton LA, Wolfe J, Parekh N, Salane M, Carter C, Hoover R (2001) Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 12(2):103-110 (Pubitemid 32165267)
9. Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM (2011) Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 103(9):744-752. doi: 10.1093/jnci/djr079
10. Boyd NF (2011) Tamoxifen, mammographic density, and breast cancer prevention. J Natl Cancer Inst 103(9):704-705. doi: 10.1093/jnci/djr115
11. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF (2001) Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomark Prev 10(3):243-248 (Pubitemid 34288536)
12. Warren R (2004) Hormones and mammographic breast density. Maturitas 49(1):67-78. doi: 10.1016/j.maturitas.2004.06.013S0378-5122(04)00212-9 (Pubitemid 39209373)
13. Lin SJ, Cawson J, Hill P, Haviv I, Jenkins M, Hopper JL, Southey MC, Campbell IG, Thompson EW (2011) Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue. Breast Cancer Res Treat 128(2):505-516. doi: 10.1007/s10549-011-1346-0
14. Hariri M, Wood GA, DiGrappa MA, MacPherson M, Backman SA, Yaffe MJ, Mak TW, Boyd NF, Khokha R (2004) Experimental manipulation of radiographic density in mouse mammary gland. Breast Cancer Res 6(5):R540-R545. doi: 10.1186/bcr901bcr901
15. Kelly JL, Findlay MW, Knight KR, Penington A, Thompson EW, Messina A, Morrison WA (2006) Contact with existing adipose tissue is inductive for adipogenesis in matrigel. Tissue Eng 12(7):2041-2047. doi: 10.1089/ten.2006.12. 2041 (Pubitemid 44162861)
16. Stillaert F, Findlay M, Palmer J, Idrizi R, Cheang S, Messina A, Abberton K, Morrison W, Thompson EW (2007) Host rather than graft origin of Matrigel-induced adipose tissue in the murine tissue-engineering chamber. Tissue Eng 13(9):2291-2300. doi: 10.1089/ten.2006.0382 (Pubitemid 47404444)
17. Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N (2005) The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14(2):343-349. doi: 10.1158/1055-9965.EPI-04-0490 (Pubitemid 40270095)
18. Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH (2005) Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res 7(5):R605-R608. doi: 10.1186/bcr1260
19. Gill JK, Maskarinec G, Pagano I, Kolonel LN (2006) The association of mammographic density with ductal carcinoma in situ of the breast: the multiethnic cohort. Breast Cancer Res 8(3):R30. doi: 10.1186/bcr1507 (Pubitemid 43951066)
20. Provenzano PP, Inman DR, Eliceiri KW, Keely PJ (2009) Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 28(49):4326-4343. doi: 10.1038/onc.2009.299
21. Wang JG, Miyazu M, Xiang P, Li SN, Sokabe M, Naruse K (2005) Stretch-induced cell proliferation is mediated by FAK-MAPK pathway. Life Sci 76(24):2817-2825. doi: 10.1016/j.lfs.2004.10.050 (Pubitemid 40460327)
22. Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1:119-150. doi: 10.1146/annurev.pathol.1.110304. 100224
23. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE (2006) Generation of a functional mammary gland from a single stem cell. Nature 439(7072):84-88. doi: 10.1038/nature04372 (Pubitemid 43053633)
24. Ghosh K, Brandt KR, Reynolds C, Scott CG, Pankratz VS, Riehle DL, Lingle WL, Odogwu T, Radisky DC, Visscher DW, Ingle JN, Hartmann LC, Vachon CM (2011) Tissue composition of mammographically dense and non-dense breast tissue. Breast Cancer Res Treat. doi: 10.1007/s10549-011-1727-4
25. Lyons TR, O'Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW, Marusyk A, Tan AC, Schedin P (2011) Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 17(9):1109-1115. doi: 10.1038/nm.2416
26. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139(5):891-906. doi: 10.1016/j.cell.2009.10.027
27. McGinley JN, Thompson HJ (2011) Quantitative assessment of mammary gland density in rodents using digital image analysis. Biol Proced Online 13(1):4. doi: 10.1186/1480-9222-13-4
28. Gierach GL, Loud JT, Chow CK, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Vachon C, Gail MH, Greene MH (2010) Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat 123(1):245-255. doi: 10.1007/s10549-010-0749-7
29. Mitchell G, Antoniou AC, Warren R, Peock S, Brown J, Davies R, Mattison J, Cook M, Warsi I, Evans DG, Eccles D, Douglas F, Paterson J, Hodgson S, Izatt L, Cole T, Burgess L, Eeles R, Easton DF (2006) Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 66(3):1866-1872. doi: 10.1158/0008-5472.CAN-05-3368 (Pubitemid 43259974)
30. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95(1):30-37 (Pubitemid 36124293)
31. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285(2):171-176 (Pubitemid 32048518)